tradingkey.logo

Australia's Holista Colltech slides on dismissal of appeal

ReutersMar 10, 2025 1:43 AM

Shares of Biotech firm Holista CollTech HCT.AX fall 20% to A$0.024, set for biggest one-day drop in four months

Co says its appeal against damages totalling $2.1 mln for distribution agreement disputes with ProImmune was dismissed by the U.S. Court of Appeals

Adds that it intends to "vigorously defend" any proceedings commenced in Australia, claiming the judgment was obtained by fraud due to ProImmune's false representations

Stock slumped as much as 30% earlier in the day

Over 295,000 shares change hands, 1.2x the 30-day avg

Stock trims YTD gains to 84.6%

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI